Logo image of QIA.DE

QIAGEN N.V. (QIA.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:QIA - NL0015002CX3 - Common Stock

41.125 EUR
-0.32 (-0.77%)
Last: 11/28/2025, 5:36:15 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to QIA. QIA was compared to 19 industry peers in the Life Sciences Tools & Services industry. Both the health and profitability get an excellent rating, making QIA a very profitable company, without any liquidiy or solvency issues. QIA has a decent growth rate and is not valued too expensively. With these ratings, QIA could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

QIA had positive earnings in the past year.
QIA had a positive operating cash flow in the past year.
In the past 5 years QIA has always been profitable.
Each year in the past 5 years QIA had a positive operating cash flow.
QIA.DE Yearly Net Income VS EBIT VS OCF VS FCFQIA.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

QIA's Return On Assets of 6.19% is fine compared to the rest of the industry. QIA outperforms 73.68% of its industry peers.
Looking at the Return On Equity, with a value of 11.11%, QIA is in the better half of the industry, outperforming 68.42% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 7.44%, QIA is in the better half of the industry, outperforming 68.42% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for QIA is in line with the industry average of 7.47%.
The 3 year average ROIC (7.25%) for QIA is below the current ROIC(7.44%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.19%
ROE 11.11%
ROIC 7.44%
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
QIA.DE Yearly ROA, ROE, ROICQIA.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

With an excellent Profit Margin value of 19.58%, QIA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Profit Margin of QIA has declined.
The Operating Margin of QIA (27.02%) is better than 100.00% of its industry peers.
QIA's Operating Margin has improved in the last couple of years.
The Gross Margin of QIA (64.10%) is better than 94.74% of its industry peers.
In the last couple of years the Gross Margin of QIA has remained more or less at the same level.
Industry RankSector Rank
OM 27.02%
PM (TTM) 19.58%
GM 64.1%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
QIA.DE Yearly Profit, Operating, Gross MarginsQIA.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

8

2. Health

2.1 Basic Checks

QIA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for QIA has been reduced compared to 1 year ago.
Compared to 5 years ago, QIA has less shares outstanding
Compared to 1 year ago, QIA has an improved debt to assets ratio.
QIA.DE Yearly Shares OutstandingQIA.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
QIA.DE Yearly Total Debt VS Total AssetsQIA.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

QIA has an Altman-Z score of 3.60. This indicates that QIA is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.60, QIA is in the better half of the industry, outperforming 78.95% of the companies in the same industry.
The Debt to FCF ratio of QIA is 4.50, which is a neutral value as it means it would take QIA, 4.50 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 4.50, QIA is doing good in the industry, outperforming 78.95% of the companies in the same industry.
A Debt/Equity ratio of 0.45 indicates that QIA is not too dependend on debt financing.
QIA's Debt to Equity ratio of 0.45 is fine compared to the rest of the industry. QIA outperforms 73.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 4.5
Altman-Z 3.6
ROIC/WACC0.95
WACC7.8%
QIA.DE Yearly LT Debt VS Equity VS FCFQIA.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

QIA has a Current Ratio of 2.60. This indicates that QIA is financially healthy and has no problem in meeting its short term obligations.
QIA has a Current ratio of 2.60. This is amongst the best in the industry. QIA outperforms 100.00% of its industry peers.
A Quick Ratio of 2.30 indicates that QIA has no problem at all paying its short term obligations.
The Quick ratio of QIA (2.30) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.6
Quick Ratio 2.3
QIA.DE Yearly Current Assets VS Current LiabilitesQIA.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

QIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.62%, which is quite good.
The Earnings Per Share has been growing by 8.40% on average over the past years. This is quite good.
QIA shows a small growth in Revenue. In the last year, the Revenue has grown by 5.32%.
Measured over the past years, QIA shows a small growth in Revenue. The Revenue has been growing by 5.32% on average per year.
EPS 1Y (TTM)9.62%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%4.04%
Revenue 1Y (TTM)5.32%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%

3.2 Future

The Earnings Per Share is expected to grow by 8.80% on average over the next years. This is quite good.
Based on estimates for the next years, QIA will show a small growth in Revenue. The Revenue will grow by 7.89% on average per year.
EPS Next Y8.55%
EPS Next 2Y8.08%
EPS Next 3Y8.5%
EPS Next 5Y8.8%
Revenue Next Year5.25%
Revenue Next 2Y5.45%
Revenue Next 3Y5.86%
Revenue Next 5Y7.89%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
QIA.DE Yearly Revenue VS EstimatesQIA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
QIA.DE Yearly EPS VS EstimatesQIA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.06, which indicates a rather expensive current valuation of QIA.
Based on the Price/Earnings ratio, QIA is valued a bit cheaper than 68.42% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.31, QIA is valued a bit cheaper.
A Price/Forward Earnings ratio of 18.36 indicates a rather expensive valuation of QIA.
Based on the Price/Forward Earnings ratio, QIA is valued a bit cheaper than 68.42% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.59. QIA is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 20.06
Fwd PE 18.36
QIA.DE Price Earnings VS Forward Price EarningsQIA.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

68.42% of the companies in the same industry are more expensive than QIA, based on the Enterprise Value to EBITDA ratio.
73.68% of the companies in the same industry are more expensive than QIA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 21.87
EV/EBITDA 14.03
QIA.DE Per share dataQIA.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
QIA has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.35
PEG (5Y)2.39
EPS Next 2Y8.08%
EPS Next 3Y8.5%

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.55%, QIA is not a good candidate for dividend investing.
QIA's Dividend Yield is a higher than the industry average which is at 0.73.
With a Dividend Yield of 0.55, QIA pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 0.55%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y8.08%
EPS Next 3Y8.5%
QIA.DE Yearly Income VS Free CF VS DividendQIA.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

QIAGEN N.V.

FRA:QIA (11/28/2025, 5:36:15 PM)

41.125

-0.32 (-0.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-04 2025-11-04/dmh
Earnings (Next)02-03 2026-02-03/amc
Inst Owners89.95%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap8.92B
Revenue(TTM)2.07B
Net Income(TTM)405.37M
Analysts74.17
Price Target44.49 (8.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.55%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.14%
Min EPS beat(2)-2.4%
Max EPS beat(2)2.11%
EPS beat(4)2
Avg EPS beat(4)0.92%
Min EPS beat(4)-3.85%
Max EPS beat(4)7.8%
EPS beat(8)5
Avg EPS beat(8)1.59%
EPS beat(12)8
Avg EPS beat(12)2.59%
EPS beat(16)12
Avg EPS beat(16)5.18%
Revenue beat(2)0
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-0.72%
Max Revenue beat(2)-0.12%
Revenue beat(4)1
Avg Revenue beat(4)-0.33%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)1.43%
Revenue beat(8)1
Avg Revenue beat(8)-0.6%
Revenue beat(12)2
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)0.46%
PT rev (1m)-0.61%
PT rev (3m)-1.6%
EPS NQ rev (1m)-1.93%
EPS NQ rev (3m)-1.69%
EPS NY rev (1m)0%
EPS NY rev (3m)0.63%
Revenue NQ rev (1m)-1.91%
Revenue NQ rev (3m)-1.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE 20.06
Fwd PE 18.36
P/S 4.99
P/FCF 21.87
P/OCF 15.71
P/B 2.83
P/tB 12.95
EV/EBITDA 14.03
EPS(TTM)2.05
EY4.98%
EPS(NY)2.24
Fwd EY5.45%
FCF(TTM)1.88
FCFY4.57%
OCF(TTM)2.62
OCFY6.37%
SpS8.24
BVpS14.53
TBVpS3.18
PEG (NY)2.35
PEG (5Y)2.39
Graham Number25.89
Profitability
Industry RankSector Rank
ROA 6.19%
ROE 11.11%
ROCE 10.03%
ROIC 7.44%
ROICexc 10.67%
ROICexgc 39.98%
OM 27.02%
PM (TTM) 19.58%
GM 64.1%
FCFM 22.82%
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexgc growth 3Y-31.24%
ROICexgc growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score8
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 4.5
Debt/EBITDA 2.17
Cap/Depr 97.52%
Cap/Sales 8.94%
Interest Coverage 250
Cash Conversion 87.76%
Profit Quality 116.56%
Current Ratio 2.6
Quick Ratio 2.3
Altman-Z 3.6
F-Score8
WACC7.8%
ROIC/WACC0.95
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)9.62%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%4.04%
EPS Next Y8.55%
EPS Next 2Y8.08%
EPS Next 3Y8.5%
EPS Next 5Y8.8%
Revenue 1Y (TTM)5.32%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%
Revenue Next Year5.25%
Revenue Next 2Y5.45%
Revenue Next 3Y5.86%
Revenue Next 5Y7.89%
EBIT growth 1Y18.55%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year57.27%
EBIT Next 3Y22.23%
EBIT Next 5Y15.78%
FCF growth 1Y71.67%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y52.1%
OCF growth 3Y1.77%
OCF growth 5Y15.28%

QIAGEN N.V. / QIA.DE FAQ

What is the fundamental rating for QIA stock?

ChartMill assigns a fundamental rating of 7 / 10 to QIA.DE.


What is the valuation status of QIAGEN N.V. (QIA.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to QIAGEN N.V. (QIA.DE). This can be considered as Fairly Valued.


How profitable is QIAGEN N.V. (QIA.DE) stock?

QIAGEN N.V. (QIA.DE) has a profitability rating of 8 / 10.


What is the valuation of QIAGEN N.V. based on its PE and PB ratios?

The Price/Earnings (PE) ratio for QIAGEN N.V. (QIA.DE) is 20.06 and the Price/Book (PB) ratio is 2.83.


How financially healthy is QIAGEN N.V.?

The financial health rating of QIAGEN N.V. (QIA.DE) is 8 / 10.